Impel Pharmaceuticals
Stock Forecast, Prediction & Price Target
Impel Pharmaceuticals Financial Estimates
Impel Pharmaceuticals Revenue Estimates
Impel Pharmaceuticals EBITDA Estimates
Impel Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | |||
Revenue
% change YoY
| $0 N/A | $668K 0% | $12.65M 1794.01% | Avg: $160M Low: $160M High: $160M avg. 1164.62% | |||
Net Income
% change YoY
| $-45.79M N/A | $-76.53M -67.11% | $-129.44M -69.12% | Avg: $19.92M Low: $19.92M High: $19.92M avg. 115.39% | |||
EBITDA
% change YoY
| $-44.25M N/A | $-71.48M -61.52% | $-83.18M -16.36% | Avg: $0 Low: $0 High: $0 avg. 100% | |||
EPS
% change YoY
| -$3.49 N/A | -$5.24 -50.14% | -$5.52 -5.34% | Avg: $0.85 Low: $0.85 High: $0.85 avg. 115.39% | |||
Operating Expenses
% change YoY
| $45.33M N/A | $71.46M 57.63% | $89.34M 25.01% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
FAQ
What is Impel Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 115.39% in 2025-2025.
We have gathered data from 1 analysts. Their low estimate is 19.92M, average is 19.92M and high is 19.92M.
What is Impel Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 1164.62% in 2025-2025.
We have gathered data from 1 analysts. Their low revenue estimate is $160M, average is $160M and high is $160M.
What is Impel Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 115.39% in 2025-2025.
We have gathered data from 1 analysts. Their low earnings per share estimate is $0.85, average is $0.85 and high is $0.85.